🇺🇸 FDA
Patent

US 6682741

&bgr;2 microglobulin fusion proteins and high affinity variants

expired A61KA61K2039/55516A61K2039/57

Quick answer

US patent 6682741 (&bgr;2 microglobulin fusion proteins and high affinity variants) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
64
CPC classes
A61K, A61K2039/55516, A61K2039/57, A61K38/00, A61K39/39